The global Parkinson's disease Treatmentmarket was valued at USD 3.94billion in 2016 and is projected to reach USD 6.65billionby 2025, growing at a CAGR of 5.99% from 2017 to 2025.
The disorder has currently ongoing research for finding a reliable treatment method and is the topic of interest for major players in the healthcare and medical sector. The market is thus expected to grow at a high CAGR during the forecast period.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing Geriatric Population
1.2 Growing number of cases of Parkinson's disorder
1.3 Availability of fund
2. Market Restraints
2.1 Presence of Alternatives
Market Segmentation:
1. By Patient Care Setting:
1.1 Clinics
1.2 Hospitals
2. By Distribution Channel:
2.1 Hospital Pharmacies
2.2 Retailer Pharmacies
2.3 Online Pharmacies
3. By Drug Class:
3.1 Carbidopa/Levodopa
3.2 Dopamine Receptor Agonists
3.3 Mao Inhibitors
3.4 Comt Inhibitors
3.5 Anticholinergics
3.6 Other Drugs
4. By Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. GSK
2. Merck
3. Novartis
4. Teva
5. BoehringerIngelheim
6. Impax
7. Abbvie
8. Valeant Pharmaceuticals
9. Lundbeck
10. Sun Pharma
11. Wockhardt
12. Acadia
13. UCB
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Parkinson's disease Treatmentmarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL PARKINSON'S DISEASE TREATMENTMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL PARKINSON'S DISEASE TREATMENTMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL PARKINSON'S DISEASE TREATMENT MARKET, BY PATIENT CARE SETTING:
5.1 Clinics
5.2 Hospitals
6 GLOBAL PARKINSON'S DISEASE TREATMENT MARKET, BY DISTRIBUTION CHANNEL:
6.1 Hospital Pharmacies
6.2 Retailer Pharmacies
6.3 Online Pharmacies
7 GLOBAL PARKINSON'S DISEASE TREATMENT MARKET, BY DRUG CLASS:
7.1 Carbidopa/Levodopa
7.2 Dopamine Receptor Agonists
7.3 Mao Inhibitors
7.4 Comt Inhibitors
7.5 Anticholinergics
7.6 Other Drugs
8 GLOBAL PARKINSON'S DISEASE TREATMENTMARKET, BY GEOGRAPHY
8.1 Overview
8.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025
9 GLOBAL PARKINSON'S DISEASE TREATMENTMARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies
10 COMPANY PROFILES
10.1 GSK
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 Merck
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 Novartis
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 Teva
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 BoehringerIngelheim
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 Impax
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 Abbvie
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
10.8 Valeant Pharmaceuticals
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
10.9 Lundbeck
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Development
10.10 Sun Pharma
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Development
10.11 Wockhardt
10.11.1 Overview
10.11.2 Financial Performance
10.11.3 Product Outlook
10.11.4 Key Development
10.12 Acadia
10.12.1 Overview
10.12.2 Financial Performance
10.12.3 Product Outlook
10.12.4 Key Development
10.13 UCB
10.13.1 Overview
10.13.2 Financial Performance
10.13.3 Product Outlook
10.13.4 Key Development
11 Appendix
11.1 Related Reports
The Treatment Management System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufac...
The Hospital Treatment Fee Evaluation Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lan...
The Chronic Kidney Disease Management Technology Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive l...
The Ion Exchange Technology For Water Treatment Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive la...
The Comprehensive Wastewater Treatment Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lan...
The Industrial Disease Prevention Systems Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...
The Cardiac Stem Cell Treatment Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufac...
The Alcohol Treatment Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufact...
The Substance Abuse Treatment Billing Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lan...
The Waste Gas Treatment System Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape...